Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities

Free article

Comment

Francesco Costa et al. J Am Coll Cardiol. 2015.

Free article

. 2015 Sep 8;66(10):1203-4.

doi: 10.1016/j.jacc.2015.05.080.

No abstract available

Comment in

Reply: Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities.
Yeh RW, Kereiakes DJ, Mauri L. Yeh RW, et al. J Am Coll Cardiol. 2015 Sep 8;66(10):1204-5. doi: 10.1016/j.jacc.2015.06.1331. J Am Coll Cardiol. 2015. PMID: 26338005 No abstract available.

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.
Yeh RW, Kereiakes DJ, Steg PG, Windecker S, Rinaldi MJ, Gershlick AH, Cutlip DE, Cohen DJ, Tanguay JF, Jacobs A, Wiviott SD, Massaro JM, Iancu AC, Mauri L; DAPT Study Investigators. Yeh RW, et al. J Am Coll Cardiol. 2015 May 26;65(20):2211-21. doi: 10.1016/j.jacc.2015.03.003. Epub 2015 Mar 15. J Am Coll Cardiol. 2015. PMID: 25787199 Free PMC article. Clinical Trial.